Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cichutek

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Developments in Biological Standardization|January 1, 1991
Epidemiology and pathogenicity of human retrovirusesR Kurth, M Baier, D Binninger, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Vaccine protection against SIVmac infection by high- but not low-dose whole inactivated virus immunogenS Hartung, S G Norley, J Ennen, et al.
Nature Biotechnology|June 3, 2000
Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cellsZ Parveen, A Krupetsky, M Engelstädter, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Development of a quasispecies of human immunodeficiency virus type 1 in vivoK Cichutek, H Merget, S Norley, et al.
Gene Therapy|May 30, 2008
Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissueL J Duerner, A Schwantes, I C Schneider, et al.
Virology|July 13, 2000
Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1J Stitz, C J Buchholz, M Engelstädter, et al.
Gene Therapy|April 8, 2011
RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectorsT Schaser, C Wrede, L Duerner, et al.
AIDS (London, England)|October 1, 1991
Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of HIV-1K Cichutek, S Norley, R Linde, et al.
Journal of Virology|April 3, 1998
The U3 promoter and the nef gene of simian immunodeficiency virus (SIV) smmPBj1.9 do not confer acute pathogenicity upon SIVagmS Wagener, M T Dittmar, B Beer, et al.
Gene Therapy|February 13, 2009
Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivityS Funke, I C Schneider, S Glaser, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Developments in Biological Standardization|January 1, 1991
Epidemiology and pathogenicity of human retrovirusesR Kurth, M Baier, D Binninger, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Vaccine protection against SIVmac infection by high- but not low-dose whole inactivated virus immunogenS Hartung, S G Norley, J Ennen, et al.
Nature Biotechnology|June 3, 2000
Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cellsZ Parveen, A Krupetsky, M Engelstädter, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Development of a quasispecies of human immunodeficiency virus type 1 in vivoK Cichutek, H Merget, S Norley, et al.
Gene Therapy|May 30, 2008
Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissueL J Duerner, A Schwantes, I C Schneider, et al.
Virology|July 13, 2000
Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1J Stitz, C J Buchholz, M Engelstädter, et al.
Gene Therapy|April 8, 2011
RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectorsT Schaser, C Wrede, L Duerner, et al.
AIDS (London, England)|October 1, 1991
Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of HIV-1K Cichutek, S Norley, R Linde, et al.
Journal of Virology|April 3, 1998
The U3 promoter and the nef gene of simian immunodeficiency virus (SIV) smmPBj1.9 do not confer acute pathogenicity upon SIVagmS Wagener, M T Dittmar, B Beer, et al.
Gene Therapy|February 13, 2009
Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivityS Funke, I C Schneider, S Glaser, et al.
Pageof 6